These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27666466)

  • 1. Juvenile myasthenia gravis in Norway: A nationwide epidemiological study.
    Popperud TH; Boldingh MI; Brunborg C; Faiz KW; Heldal AT; Maniaol AH; Müller KI; Rasmussen M; Øymar K; Kerty E
    Eur J Paediatr Neurol; 2017 Mar; 21(2):312-317. PubMed ID: 27666466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholine receptor antibodies in juvenile myasthenia gravis.
    Andrews PI; Massey JM; Sanders DB
    Neurology; 1993 May; 43(5):977-82. PubMed ID: 8492956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and Ocular Features of Pediatric Myasthenias.
    Mansukhani SA; Bothun ED; Diehl NN; Mohney BG
    Am J Ophthalmol; 2019 Apr; 200():242-249. PubMed ID: 30653958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of myasthenia gravis in Northern Portugal: Frequency estimates and clinical epidemiological distribution of cases.
    Santos E; Coutinho E; Moreira I; Silva AM; Lopes D; Costa H; Silveira F; Nadais G; Morais H; Martins J; Branco MC; Veiga A; Silva RS; Ferreira A; Sousa F; Freijo M; Matos I; André R; Negrão L; Fraga C; Santos M; Sampaio M; Lopes C; Leite MI; Gonçalves G
    Muscle Nerve; 2016 Sep; 54(3):413-21. PubMed ID: 26851892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seropositive myasthenia gravis: a nationwide epidemiologic study.
    Heldal AT; Owe JF; Gilhus NE; Romi F
    Neurology; 2009 Jul; 73(2):150-1. PubMed ID: 19597135
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa.
    Mombaur B; Lesosky MR; Liebenberg L; Vreede H; Heckmann JM
    Muscle Nerve; 2015 Apr; 51(4):533-7. PubMed ID: 25060190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of myasthenia gravis in Norway.
    Storm-Mathisen A
    Acta Neurol Scand; 1984 Oct; 70(4):274-84. PubMed ID: 6507037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries.
    Andersen JB; Heldal AT; Engeland A; Gilhus NE
    Acta Neurol Scand Suppl; 2014; (198):26-31. PubMed ID: 24588503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile myasthenia gravis in Norway: Clinical characteristics, treatment, and long-term outcome in a nationwide population-based cohort.
    Popperud TH; Boldingh MI; Rasmussen M; Kerty E
    Eur J Paediatr Neurol; 2017 Sep; 21(5):707-714. PubMed ID: 28457757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands.
    Niks EH; Kuks JB; Verschuuren JJ
    J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):417-8. PubMed ID: 17056627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile Myasthenia Gravis in North Texas: Clinical Features, Treatment Response, and Outcomes.
    Lu M; Reisch J; Iannaccone S; Batley K
    Pediatr Neurol; 2024 Jul; 156():10-14. PubMed ID: 38688232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile myasthenia gravis with prepubertal onset.
    Evoli A; Batocchi AP; Bartoccioni E; Lino MM; Minisci C; Tonali P
    Neuromuscul Disord; 1998 Dec; 8(8):561-7. PubMed ID: 10093062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis in childhood.
    Anlar B; Ozdirim E; Renda Y; Yalaz K; Aysun S; Topçu M; Topaloğlu H
    Acta Paediatr; 1996 Jul; 85(7):838-42. PubMed ID: 8819551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and evolution of juvenile myasthenia gravis in a French cohort.
    Barraud C; Desguerre I; Barnerias C; Gitiaux C; Boulay C; Chabrol B
    Muscle Nerve; 2018 Apr; 57(4):603-609. PubMed ID: 28877546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nationwide epidemiological study of myasthenia gravis in Latvia.
    Zieda A; Ravina K; Glazere I; Pelcere L; Naudina MS; Liepina L; Kamsa I; Kurjane N; Woodhall M; Jacobson L; Leite MI; Tandon K; Kenina V
    Eur J Neurol; 2018 Mar; 25(3):519-526. PubMed ID: 29194859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographics and ocular findings in children with myasthenia.
    Arruti N; Munot P; Bowman R
    Eye (Lond); 2023 Mar; 37(4):700-704. PubMed ID: 35338356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A national epidemiological study of Myasthenia Gravis in Australia.
    Gattellari M; Goumas C; Worthington JM
    Eur J Neurol; 2012 Nov; 19(11):1413-20. PubMed ID: 22469211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of children with acetylcholine receptor (AChR) antibody positive juvenile myasthenia gravis following thymectomy.
    Heng HS; Lim M; Absoud M; Austin C; Clarke D; Wraige E; Reid C; Robb SA; Jungbluth H
    Neuromuscul Disord; 2014 Jan; 24(1):25-30. PubMed ID: 24239058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Epidemiology of Myasthenia Gravis in Korea.
    Lee HS; Lee HS; Shin HY; Choi YC; Kim SM
    Yonsei Med J; 2016 Mar; 57(2):419-25. PubMed ID: 26847295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological and immunological profile of muscle-specific kinase myasthenia gravis in Greece.
    Tsiamalos P; Kordas G; Kokla A; Poulas K; Tzartos SJ
    Eur J Neurol; 2009 Aug; 16(8):925-30. PubMed ID: 19374661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.